Bupivacaine %0.25 (isobaric) is one of 123 small molecule programs targeting Lung Disease. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
61 competitors in Post Operative Pain
Marcaine
Advil
Precedex
Ketalar
Oxycontin
Epsom Salt
Tylenol
Suboxone
Achromycin V
EXPAREL
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details